DAVITA INC. is 6.4x more valuable than Progyny, Inc. by market capitalization ($12.83 B vs $2.01 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PGNY | DVA |
|---|---|---|
| Market cap | $2.01 B | $12.83 B |
| US-listed rank | #2101 | #809 |
| Revenue (latest FY) | $1.29B | $13.64B |
| Net income (latest FY) | $58.52M | $1.08B |
| Net margin | 4.5% | 7.9% |
| P/E (trailing FY) | 34.4 | 11.9 |
| SEC filings | 893 | 3,248 |
DAVITA INC. is 6.4x more valuable than Progyny, Inc. by market capitalization ($12.83 B vs $2.01 B).
In their latest fiscal years, Progyny, Inc. reported $1.29B in revenue while DAVITA INC. reported $13.64B.
Full pages: Progyny, Inc. and DAVITA INC., or browse the full rankings.